Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Genaera reaches SPA agreement on phase III trials for Evizon

June 30, 2005

Pre-NDA meeting for AzaSite

June 30, 2005

Sucampo suspends tacrolimus eye drops development program

June 29, 2005

Duska acquires P2 receptor-based technology to treat glaucoma

June 21, 2005

Enzo acquires rights to drug candidate for treating uveitis

June 16, 2005

Potassium channel blockers for glaucoma, etc., emerge from Merck & Co. research

June 14, 2005

Target enrollment reached in phase II wet AMD study of Evizon

June 13, 2005

Phase IIb study of NP-50301 for dry eye syndrome completes enrollment

June 9, 2005

Inspire submits NDA amendment for diquafosol for dry eye

June 3, 2005

First phase I study of OT-551 for cataracts meets all safety and comfort endpoints

May 30, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...